Presented on Tuesday, May 24, 2022
NRx Pharmaceuticals interim Chief Executive Officer, Robert Besthof, and other executive leaders presented a virtual update to the company’s business via webcast at the H.C. Wainwright & Co. Global Investment Conference.
Webcast Presentation Details
Event: H.C. Wainwright Global Investment Conference (Hybrid Conference)
Date Presented: Tuesday, May 24, 2022
Time: 7:00 a.m. Eastern Time
